Expansion into New Markets in the Environmental Hygiene Sector
First written in FY2017. 5 of 12 entries say "Advanced", first in FY2020. Latest entry: FY2026.
The whole theme swung hardest in 2024: 1 of 6 companies on the "Worse" side.
3 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「In fiscal 2025, we produced a water-treatment reactor and verified the effectiveness of the technology at a development partner company.」
In the environmental health and Life Science fields, the Company produced a water-treatment reactor for on-site decomposition of PFAS and progressed through effectiveness verification at a partner company. - FY2024Lower environmental health business sales and restrained investmentAnnual report
「Revenue declined mainly because sales of light sources for environmental health applications fell. Meanwhile, profit increased because the inventory valuation loss recognized in the previous fiscal year declined and investment was restrained following a strategic review of the environmental health business.」
While sales of light sources for environmental health applications continued to decline, the loss narrowed due to restrained investment following a strategic review and the absence of the inventory valuation loss recognized in the previous fiscal year. - FY2024-Q2Lower environmental health sales and restrained investmentAnnual report
「Revenue declined mainly because sales of light sources for environmental health applications fell. Meanwhile, profit increased because an inventory valuation loss had been recognized in the previous fiscal year and investment was restrained following a strategic review of the environmental health business.」
While sales of light sources for environmental health applications continued to decline, investment was restrained following a review of the business strategy, and the Life Science business narrowed its loss partly due to the absence of the inventory valuation loss recognized in the previous fiscal year. - FY2024-Q1Sluggish sales of environmental health products and restraint of promotional expensesAnnual report
「Sales remained flat, mainly because sales of ultraviolet treatment equipment and other products remained solid. Meanwhile, we restrained promotional expenses and other costs, primarily for environmental health products whose sales remained sluggish.」
In the Life Science business, ultraviolet treatment equipment and other products performed solidly, while promotional expenses and other costs were restrained in response to sluggish sales of environmental health products. - FY2023AdvancedAnnual report
「In fiscal 2022, we developed and sold the new i-FT series of units, which can irradiate a wider area with a single unit. ... We are also developing compact modules to expand applications, have completed prototype modules and are using them to gather customer feedback on their needs.」
For Care222, the Company developed and sold the i-FT series for irradiation over a wider area, and compact modules progressed to the prototype completion stage. - FY2022Failure to meet sales plans and ongoing challengesAnnual report
「We will promote future business expansion for products equipped with Care222 ultraviolet technology for antiviral and disinfection applications by strengthening measures to overcome the challenges.」
After the launch of the Care222-equipped products, sales fell short of expectations due to delays in regulatory easing in various countries, insufficient awareness and delays in disseminating understanding of ultraviolet safety. The policy is to continue strengthening measures to overcome these challenges. - FY2022-Q2Sales below plan and ongoing issuesAnnual report
「Sales of Care222®-related products using antiviral ultraviolet irradiation technology, which had been launched in the market in the previous fiscal year as environmental health-related products, increased year on year but fell short of expectations because obtaining product safety certification for Care222®-equipped products in the United States took time and due to responses to unit defects in Japan.」
Sales of Care222-related products increased year on year, but results fell short of expectations due to delays in obtaining U.S. product safety certification and responses to unit defects in Japan. - FY2022-Q1AdvancedAnnual report
「Sales also increased for irradiation equipment and light source modules equipped with Care222 ultraviolet irradiation technology for antiviral and disinfection applications, which had been launched in the market in the previous fiscal year as environmental health-related products.」
Sales of Care222-equipped irradiation equipment and light source modules increased following their market launch in the previous fiscal year. - FY2021AdvancedAnnual report
「Demand for Care222 ultraviolet technology for antiviral and disinfection applications rose rapidly in the environmental health sector, prompting investment in mass production, the establishment of a mass-production system and the launch of sales.」
Expansion into environmental health progressed to the stage of investing in mass production, establishing a mass-production system and launching sales in response to growing demand for Care222. - FY2020AdvancedAnnual report
「As interest in a safe and secure society grows amid the spread of the novel coronavirus (COVID-19), we will contribute to the realization of a safe and secure environment without pandemics by concentrating resources on sales of Care222 ultraviolet lamps, which contribute to virus inactivation, in the new environmental health business and seeking to commercialize the business at an early stage.」
The new-market strategy in environmental health has progressed to specific measures: concentrating resources on Care222 ultraviolet lamps, which contribute to virus inactivation, and pursuing early commercialization. - FY2019RestatedAnnual report
「Specifically, we will focus on new market needs in environmental health and the electronics sector, including semiconductors, and seek to expand our business.」
The policy of pursuing environmental health and the electronics sector, including semiconductors, as new market opportunities remains in place. - FY2017First statedAnnual report
「Specifically, we will focus on areas such as environmental health, including space disinfection, food hygiene and food cultivation, as new markets and seek to expand our business.」
The Company has for the first time indicated a policy of developing environmental health, including space disinfection, food hygiene and food cultivation, as a new market.